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INTRODUCTION
Nitrogenase, the enzyme system responsible for biological
nitrogen fixation is found only among a minority of the
procaryotic organisms. But the process it catalyzes is neverthless
of great importance for life on earth; without it, the available
supplies of combined nitrogen would soon be depleted by
denitrif ication. Industrial fertilizers are energy costly, and
although this is also true for biological nitrogen fixation, the
organisms involved use solar energy more directly without
intervening steps of technology.
Major research efforts on the biochemistry of nitrogen
fixation are justified by curiosity about how enzyme proteins can
carry out the difficult (for the chemists) process of reducing
dinitrogen to ammonia under such mild conditions. The research is
also justified by the need to define the biochemical requirements
for nitrogen fixation before work in genetics, ecology and agronomy
can be realistically expected to increase the number of useful
nitrogen fixing system.
1. Nitrogenase and Its Structure
The nitrogenase complex consists of two proteins; Fe protein
and MoFe protein. Although the two proteins can be completely
separated, and they can be obtained free of other proteins by
standard techniques, neither of them is catalytically active in the
absence of the other; these proteins must interact and form a
complex during the catalysis. Both proteins are rapidly inactivated
by oxygen (the Fe protein to the greater extent, half life in air
about 30 sec), therefore they must be handled under strictly
anaerobic conditions. Anaerobic techniques limit the number of
experiments performed per nitrogenase enzymologist, and it causes
another problem, that the presence of unknown portion of oxygen
inactivated proteins introduces ambiguity in the data and their
interpretations
.
The Fe protein is a dimer, composed of two identical
subunits. It has a molecular weight of about 60,000, containing
four acid-labile sulfurs and four atoms which form one [4Fe 4S]
cluster per Fe protein of two subunits (1). The [4Fe 4S] cluster
bridges two identical subunits, being anchored through two
cysteines on each subunit. Recently two particular cysteines (#97,
#132) were identified as likely ligands to the [4Fe 4S] center
(4). The amino acid sequence of Fe protein from eight different
species has been determined (5-12). The amino acid sequences are
highly conserved (13), although the organisms represent five genera
{Azotobacter , CI os tri di urn , Anabaena , Klebsiella . and Rhizobium )
from diverse ecological niches and time of evolutionary divergence;
the C. pasteurianum amino acid sequence is most different from all
others, even it shares 60% residues in common with others. Crystal
structure determination is in progress (14).
The MoFe protein is an dx px tetramer with a molecular
weight of 220,000 (1). It contains two atoms of molybdenum, and
although the precise number of Fe atom is not known yet; the best
values range from 24-32 (2). Acid labile sulfurs are present in
about equal number as Fe. Isolation of FeMo cofactor (3), probably
having a ratio of Fe to S to Mo of 8:6:1 and showing a similar
electron paramagnetic resonance (epr) spectrum to that of intact
MoFe protein, might be helpful for understanding the role of
molybdenum at the active site and N 2 activating site in the MoFe
protein.
2. Mechanism of Nitrogenase Catalysis
The conversion of dinitrogen to ammonia by nitrogenase
complex requires both component proteins, a source of reducing
equivalent, MgATP, protons, and anaerobic conditions. The
stoichiometry of the reacion catalyzed by nitrogenase complex is
N 2 + 6e- + 12 MgATP + 8 H + ==) 2 NH 4 + + 12 MgADP + 12Pi
In most N fixing microorganisms, the sourse of electron is reduced
ferridoxin. ATP and divalent metal ion, usually Mg, are absolute
requirements for any electron transfer reactions by nitrogenase
while MgADP, the product of MgATP utilization by enzyme, inhibits
nitrogenase activity. Although there is not complete agreement, it
is usually assumed that 12 moles of ATP are required for 1 mole of
nitrogen reduced to 2 moles of ammonia (1). Relatively few details
concerning regulation of the activity of nitrogenase are known.
Direct control of nitrogenase activity may be mediated through the
ATP : ADP ratio in the vicinity of the enzyme thereby regulating
the rate at which the enzyme reduces substrate (2).
(1) Turnover
The overall steps in nitrogenase catalysis have been reviewed
(1). There are no known species different with respect to the
overall steps, although the individual rate constant may vary.
Mechanistic information has only come from studies with the
artificial electron donor dithionite (S 2 4
-2
) where S0 2 * is the
actual one electron donor. The overall steps are concisely
summarized as follow. Fe is an abbreviation of Fe protein and MoFe
is an abbreviation of MoFe protein.
(a) reduction of Fe protein by electron donor
Feox (MgADP) 2 + 2MgATP + S02 - =^ Fered (MgATP) 2 + 2MgADP + S0 2
(b) complex formation
[Fered (MgATP) 2 ] x + MoFeox ==^ [Fered (MgATP) 2 ] x MoFeox
where x usually equal to 2 but can be 1 (15)
(c) electron transfer coupled to MgATP hydrolysis
[Fered (MgATP) 2 ] x MoFeox ==$ [Feox (MgADP + Pi) 2 ] x MoFered
There is a general agreement that this step is rapid and
irreversible.
(d) complex dissociation
[Feox (MgADP + Pi) 2 ] xMoFered ===) Feox (MgADP) 2 + 2Pi + MoFered
Free reduced MoFe protein might later transfer its electron to
substrate, without the help of Fe protein.
(2) Substrate Reduction
Besides dinitrogen, a number of other molecules and ions can
be reduced through nitrogen catalysis, e.g., N 2 0, N 3 ~, C2H2, HCN,
CH3NC, H+ . Of these, the reduction of acetylene to ethylene is of
great pratical importance for the measurement of nitrogenase in
vivo and in vitro activity since this reduction can be easily
estimated by gas chromatography. Reduction of protons to dihydrogen
is also important since this substrate is always present with
active nitrogenase systems.
3. Binding Of MgATP To The Nitrogenase Fe Protein
Electron transfer from Fe protein to MoFe protein is coupled
to ATP hydrolysis. Relatively little is known about the role of
MgATP in nitrogenase hydrolysis. Bui and Mortenson used gel
filtration to show that ATP binds to Fe protein, but not to the
MoFe protein (16). Tso and Burris extended equilibrium binding
studies to quantitative experiments with a gel filtration technique
(17). They found that ATP binds to two independent and equivalent
sites on the Fe protein with a site-specific dissociation constant,
Ks, 17 uM. ADP competes for binding for one site, but at the same
time ADP increases the affinity of the other site for ATP. The
dissociation constant for ADP is 5 uM.
Zumft et al (18) proposed that ATP induced a conformational
change in Fe protein because the changes that ATP binding caused in
the electron paramagnetic resonance (epr) spectrum were similar to
those spectral changes obtained when Fe protein was in the
presence of 5.0 M urea.
Walker et at (19) reported that ATP-induced conformational
change probably involved a reorientation of the iron sulfur center
of Fe protein since the iron in reduced Fe protein was accessible
to an iron chelator, t^,*'- dipyridyl, in the presence of MgATP but
not in its absence.
Hausinger and Howard (4) have shown that cys #85 residue is a
likely nucleotide binding site. This residue is not a normally
exposed, chemically reactive residue, but one which becomes exposed
when iron-sulfer center is destroyed.
All these recent data support the idea that MgATP binding to
the Fe protein dramatically influences the environment around the
iron-sulfur center, which suggests close interaction between the
MgATP binding site and iron sulfur center.
4. In Vitro Assay Of Nitrogenase Activity
Generally, for in vitro assays of nitrogenase activity,
dithionite is used as an electron donor and the level of ATP is
maintained high and nearly constant by using an ATP-regenerating
system. The ATP-regenerating system consists of creatine phosphate,
creatine kinase and set amount of ATP and Mg+2 and carries out the
following reaction.
MgATP-2 + creatine f—> MgADP" + creatine phosphate-2 + H+
E: creatine kinase
It is assumed that the regenerating system responds in an ideal
fashion so that the steady-state concentration of the essential
substrate remains constant at the initial level while the
concentration of inhibitor (e.g., MgADP) is negligible over the
course of assay.
To meet the above purpose, the following conditions must be
considered (20).
1) The effect of pH on the function of creatine kinase is
complicated; at high pH the equilibrium is no longer overwhelmingly
in the favor of ATP production and at low pH, the metal binding of
nucleotides is reduced and dithionite is unstable. Therefore the pH
between 7 and 8 must be maintained.
2) Mg as the acetate should be added in ImM excess over [ATP] to
ensure that all of ATP exists as the MgATP complex.
3) Cl~ or other commonly used anions inhibit creatine kinase
activity.
5. Study Of Nitrogenase Using Nucleotide Analogs
Hausinger and Howard (4) identified two cysteines (#97, #132)
as likely ligands to the iron sulfur center while another appeared
to be involved in ATP binding (#85) using a chemical labeling
method by alkylation with iodoacetic acid under various condition.
Relatively few studies of covalent modification have been done with
nitrogenase.
Robson (22) proposed that Fe protein has an ATP binding site
similar to that of many nucleotide binding enzymes. The specific
amino acid residues within the nucleotide binding site of several
enzymes were identified using affinity labeling by 5'-
Fluorosulf ony 1 benzoyl adenosine (5'-FSBA) (23,24,25). The
structure of 5'-FSBA (showm below) resembles that of ATP but it
contains sulfonyl fluoride group which can act as an electrophilic
agent in covalent reaction within several classes of amino acid
including tyr, lys, his, ser, and cys. Thus it might reasonably be
expected that 5'-FSBA would react with amino acid residues directly
within adenine nucleotide binding sites in proteins (26). Therefore
this affinity labeling reagent may be able to be used as a
structural probe for nitrogenase. The studies in this paper are
designed mainly to examine the interaction and kinetics of
nitrogenase when it reacts with 5'-FSBA, before any attempt for a
structural probe.
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II. MATERIALS AND METHODS
Source of chemicals
Adenosine triphosphate (ATP): Sigma Chemical Co.
Adenosine diphosphate (ADP): Sigma Chemical Co.
Creatine phosphate: Sigma Chemical Co.
Creatine kinase: Sigma Chemical Co.
5'-Fluorosulfonyl benzoyl adenosine (5'-FSBA): Sigma
Chemical Co.
Pheny lmethane sulfonyl fluoride (PMSF): Sigma
Chemical Co.
Sodium dithionite (DTH): Fisher Scientific Co.
Calcium carbide (CaC 2 ): Fisher Scientific Co.
Trishydroxymethylaminomethane (Tris): Fisher Scientific
Co.
37% (w/w) Formaldehyde (HCHO): Fisher Scientific Co.
2-(N-Morpholino)propane-sulfonic acid (MOPS): Sigma
Chemical Co.
N, N - Dimethyl formamide (DMF): Fisher Scientific Co.
<^A -Dipyridyl: J. T. Baker Chemical Co.
Mg acetate: Fisher Scientific Co.
1. Chemical Methods
(1) Acetylene Reduction Assay (21)
Materials
1. Standard ATP mix;
315mg creatine phosphate
48mg ATP
6mg creatine kinase
16.5ml 50mM Tris.Mops buffer, pH 7.4
1.5ml 0.1M Mg acetate (MgAc)
2. Sodium dithionite solution: lOOmM Na 2S 204 (DTH)
105mg sodium dithionite was dissolved in 6ml of
0.013N NaOH solution under anaerobic conditions prior to
use. Before dissolving sodium dithionite with anaerobic
NaOH, sodium dithionite must be capped with a rubber
stopper and evacuated to replace air with argon gas
under atmospheric pressure.
3. 37% (W/W) HCHO or 30% (W/V) trichloroacetic acid (TCA)
4. C 2 H2 gas;
Acetylene produced from calcium carbide and water is
used, which has adequate purity for acetylenereduction
assay.
Methods
6.3 ml serum bottles were used for acetylene reduction
assay. 1ml reation mixture contained 2.5 umole ATP, 30 umole
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creatine phosphate, 0.2 mg creatine kinase, 5 umole MgAc, and
buffer; 0.6 ml of standard ATP mix satisfies all above
concentrations. Bottles containing above constituents were
evacuated and flushed 3 times with Ar gas. 0.5 ml acetylene gas and
20 umole dithionite solution was added just before the addition of
enzyme fraction. Assays were run at 30°C for an indicated time in a
water-bath shaker. Acetylene reduction reactions were terminated by
injecting 0.1ml of 30% TCA or 37% HCHO to the solution. Ethylene
production was measured after 30 min with a Varian Aerograph 1200
gas chromatograph.
Sample peak squares can be converted to nmole, calibrating
with an ethylene standard peak. The way to get the standard peak
is described; ethylene and acetylene gas, each one mililiter, were
injected into 125ml vaccine bottle capped with a rubber stopper.
The amount of acetylene and ethylene in this bottle is calculated
as follows.
lml/24,000ml/mole x lml/125ml = 333 x 10~9 mole/ml
Therefore, if 300 ul of the bottle content is injected, it must
give 100 nmole of both acetylene and ethylene.
333 x 10~ 9mole/ml x 300 ul x 10~ 3ml/l = 99.9 x 10" 9 mole
= 100 nmole
To get a standard peak, 300 ul of the bottle contents was injected
into Varian Aerograph 1200 and peaks were counted by their squares.
To get sample peak, 500 ul gaseous phase was injected, peaks were
counted, and converted to nmole per sample as shown next.
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calibration factor x concentration (nmole) x dilution factor
= nmole/sample bottle
where
square x attenuator x sensitivity of sample
calibration factor =
square x attenuator x sensitivity of std.
concentrations = 100 nmole
total vial vol - liquid vol 6.3 - 1.0 ml
dilution factor - =
sample size 0.5 ml
In the experiment performed for this paper, all the activity
was shown as reduced C 2 H 2 nmole/min/assay and each assay condition
was as descrived above. The gas chromatograph detector was hydrogen
flame ionization detector and the carrier gas was nitrogen. The
column temperature was at 70°C, injector temperature at 38°C, and
detector temperature at 130°C.
< Enzyme titration>
Acetylene reduction activity is dependent on the ratio of two
components of nitrogenase as well as C 2 H 2 concentration (27). It
is necessary to titrate one component against the other until
optimum specific activity based on both components is reached to
get a suitable system for kinetic studies of nitrogenase.
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Methods
Six reaction vials containing reagents except AV II were
prepared by the following protocol anaerobically and incubated at
30° C for 6 minutes. As per time schedule, ten ul of component II
was added and after 5 minutes the reaction was stopped and the
activity was measured. The enzyme titration curve, the plot of
measured activity vs the amount of added component I provides the
information about the component ratio to be used.
run ATP lOOmM
mix DTH
C2 H 2
gas
Hc.0 buffer comp I comp II
1
2
3
4
5
6
600 200 500 100
(unit: ul)
90 1
85 5
80 10
75 15
65 25
75 25
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(2) Fe Determination By *,*- dipyridyl
dA ~ dipyridyl (structure shown below) is a reagent for the
determination of iron; it chelates ferrous iron resulting in a
colored product, a ferrous o*,<X -dipyridyl complex which has a molar
extinction 8400 at 520 nm. It has been proposed that the reason
that these compounds form such stable complexes with Fe is that
iron-chelator-complex exists in the form of five membered aromatic
ring capable of assuming several resonance structures (28).
R = N,0
2 CjLc.R: + M<
-to'
This color reaction was exploited to determine Fe of Fe
protein in various conditions. To protect enzyme from being
denatured by oxygen, absorbance was measured anaerobical ly by
Beckman UV spectrometer.
.
r
structure of d ,d -dipyridyl
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2. Enzyme Studies
The enzyme used in this experiment was isolated from
Azotobacter vinelandii which are free living bacteria, being able
to fix nitrogen without the cooperation of other organisms. For the
nitrogenase system of Azotobacter vinelandi i , component. I and II
are commonly denoted by AV 1 and AV II, respectively. The enzymes
used in this experiment were obtained from several different
vessels which were isolated as different fractions, at different
preparation date. Therefore for each different vessel of enzyme,
enzyme titration was performed to get the suitable component ratio
to be used.
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(1) 5'-FSBA Effect On Each Separated Component
This experiment is designed to determine whether 5'-FSBA has
a specific inhibition of either component I or II from Azotobacter
vinelandi
i
or whether both need to be present for the inhibition.
Since Dr. Davis's earlier observation (unpublished) showed that 5'-
FSBA inhibition was stronger in the presence of MgADP than 5'-FSBA
alone, all the samples were reacted in the presence of MgADP.
Reagents:
1 standard ATP mix
2. 100 mM sodium dithionite solution (DTH)
3. acetylene gas
4. 37% (W/W) HCHO
5. 50 mM Tris Mops buffer, pH 7.4
* all above are prepared as described in chemical methods.
6. N,N - Dimethyl formamide (DMF)
7. 25 mM 5'-FSBA solution:
2.45 mg of 5'-FSBA was dissolved in 0.2 ml of DMF
solution anaerobical ly. Since 5'-FSBA was not stable in
DMF solution for a long time, fresh solution was prepared
prior to use.
8. 100 mM Mg acetate in distilled water
9. 50 mM ADP solution in distilled water
10. AV I solution
11. AV II solution
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EXPERIMENT (l)-a, 5'-FSBA effect on AV I
(The enzyme used was AV I, 5/5/81, A #5 and AV II, 5/4/81, A #1)
Table 1. Enzyme Titration Data
AVI (ul) AVII (ul) activity (nmole/min)
1() 0.58
5 6.99
10 13.30
15 14.10
25
^'
17.60
25 c) 0.34
Maximum activity was about 2,000 nmole/min/ml AV II and the
ratio of components, the volume ratio present in assay, was
determined to have AV I to AV II ( 1 to 2 ) in order that enzyme
activity was limited by AV I, not by AV II.
Procedure:
The reagents were prepared as shown in following protocol
anaerobically and incubated in water-bath shaker at 30°C for 6 min.
run buffer 0.1M MgAc 50mM ADP lOOmM DTH DMF 25mM FSBA
1
2
125
125
5
5
5
5
(unit: ul)
50 40
50 — 40
Time was measured by adding 65 ul of AV I. At 0, 10, 30 ,60,
17
120min, 40 ul reaction mixture was taken out and added to enzyme
assay vials which contained 300 ul ATP mix, 40 ul buffer, loo ul
DTH, 20 ul AV II and 500 ul C 2 H 2> incubating in water bath. After
5 min of addition of reaction mixture (containing 9 ul of AV I) to
the enzyme assay vial, reaction was stopped by adding 0.1 ml of 37%
HCHO solution and 500 ul gas sample was injected into gas
chromatograph.
EXPERIMENT (l)-b 5'-FSBA effect on AV II
(The enzyme used was AV I, 5/5/81, B #4 and AV II, 4/16/80 )
Table 2 Enzyme Titration Data
AV I (ul)
5
10
15
25
25
AV II (ul)
10
activity ( nmole/min )
0.18
6.40
9.60
13.90
13.20
0.00
Maximum activity was about 1,400 nmole/min/ml AV II and enzyme
component volume ratio was determined to have excess of AV I over
AV II (2.8 : 1) in order that enzyme activity was limited by AV II,
not by AV I.
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Procedure:
Same as experiment 1-a except that AV II (65 ul) was added to
the reaction bottle instead of AV I and AV I (25 ul) instead of AV
II (20 ul) was added to enzyme assay bottle.
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(2) 5'-FSBA Effect On Mixed Components
In experiment (1), 5'-FSBA showed specific inhibition on AV
II. This experiment was designed to determine whether 5'-FSBA has
an inhibition effect on AV II when it exists in a mixed form with
AV I.
Reagents:
same as experiment (l)-b except enzyme solution.
Instead of separated components, enzyme mixture containing
AV I and AV II at a volume ratio of 2.5 to 1 was used.
Procedure:
All steps are the same as experiment (l)-b except that the
enzyme mixture (65 ul) instead of AV II was added to reaction
bottles and enzyme assay bottles contained the same amount of
buffer instead of AV I.
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(3) Phenylmethane Sulfonyl Fluoride (PMSF) Effect On AV II
This experiment was designed to know the specifity of 5'-FSBA
inhibition; was 5'-FSBA inhibition on AV II due to being a
structural analog of ATP or just due to a reactive sulfonyl
fluoride group? For this purpose, PMSF (pheny lmethane sulfonyl
fluoride, structure was shown below) which has the same reactive
sulfonyl fluoride group as 5'-FSBA and inhibits the serine protease
by reacting with active amino acid residue (29) was reacted with AV
II and its effect on enzyme activity was determined.
-H-O
structure of pheny lmethane sulfonyl fluoride (PMSF)
Reagents:
Same as experiment (1) except 5-FSBA solution and enzyme
solution. Instead of 25 mM 5'-FSBA, 25 mM PMSF solution was
prepare in DMF solution. The enzyme solution used was AV I
5/5/81, B #4 and AV II, 5/4/81, B #1.
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Table 3. Enzyme titration data
AV I ( ul) AV II ( ul) Act ivity (nmole/min)
10 0.3
5 4.8
10 8.59
15 9.69
25 -/ 12.20
25 0.02
Maximum activity was more than 1,300 nmole/min/ml AV II and the
volume ratio of AV I to AV II (2 to 5) was used.
Procedure:
The reagents were prepared in reaction vials as shown in
following protocol and placed in water-bath shaker at 30°C.
run buffer lOOmM DTH 0.1M MgAc 50mM ADP DMF 25mM PMSF
(unit: ui)
1 225 50 10 10 80 —
2 225 50 10 10 — 80
Time was measured by adding 125 ul of AV II. AT 0, 10, 30, 60, 120
minutes, 40 ul reaction mixture was taken out and added to enzyme
assay vials which contain 300 ul ATP mix, 35 ul buffer, 100 ul DTH,
25 ul AV I and 500 ul C 2 H 2 gas, incubating in water-bath shaker.
After 5 minutes of addition of reaction mixture, reaction was
stopped and activity was measured.
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(4) 5'-FSBA Inhibition With MgADP
This experiment was designed to determine 5'-FSBA inhibition
with MgADP in standard assay medium. In the enzyme assay method of
experiment (1) and (2), enzyme was incubated with 5'-FSBA and MgADP
for a certain indicated time and small aliquots of reaction mixture
were taken out and added to enzyme assay bottle to measure
activity. In this experiment, to measure continuing turnover of
catalysis upon 5'-FSBA inhibition, the reaction bottle and enzyme
assay bottle were not separated. To incubate enzyme with 5'-FSBA in
the presence of MgADP, standard ATP mix was modified as described
in reagents. However, nitrogenase enzyme activity was not
measurable without MgATP, so after different incubation time with
MgADP, creatine kinase solution was added and activity was
measured.
Reagents:
1. 2X ADP mix
creatine phosphate 620mg
ADP 72.8mg
Mg acetate 3ml
50mM Tris Mops buffer, pH 7.4 15ml
(300 ul of 2X ADP mix in 1 ml reagent volume satisfies
2.5 umole ADP, 30 umolecreat ine phosphate and 5umole
Mg acetate which need for enzyme assay.)
2. Creatine kinase solution (lOmg/ml) in 50 mM Tris Mops
buffer (20 ul of kinase solution gives 0.2 mg to 1 ml
23
reaction mixure which needs for enzyme assay.) All the other
reagents used including enzyme solution were the same as
experiment (1).
Procedure:
The following reagents were prepared in reaction vials
anaerobically and incubated in 30°C water-bath for 6 min.
run 2X ADP
mix
buffer lOOmM
DTH
AV I C2 H 2 H 2 DMF 25mM
FSBA
(unit: ul)
l 300 110 200 150 500 120 40 —
2 300 110 200 150 500 120 40
total liquid volume, 1ml
Each run is comprised of six reaction vials. As per time schedule,
60 ul of AV II was added into the reaction vials which were placed
in water-bath shaker during reaction. After each time interval (0,
10, 15, 30, 60, 90 min), 20 ul creatine kinase solution was added
to convert MgADP to MgATP and enzyme activity was measured for 5
minutes. 500 ul gaseous sample was taken out and injected to gas
chromatograph.
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(5) Time Course Of 5'-FSBA Inhibition
In experiment 4, 5'-FSBA showed a strong inhibition in 10
minutes. This experiment was designed to determine the initial
inhibition by 5'-FSBA; the enzyme activity was monitored in every 1
min up to 5 min in two different ATP concentrations. Instead of
standard ATP mix, each constituent was made separately in order to
vary ATP concentration.
Reagents:
1. 200 mM creatine phosphate prepared in 50 mM Tris Mops buffer
2. 50 mM ATP solution prepared in 50 mM Tris Mops buffer
3. 100 mM Mg acetate solution prepared in distilled water
4. Creatine kinase solution (10 mg/ml) in 50 mM Tris Mops buffer
All the other reagents were same as experiment (4). The enzyme
solution used was AV I, 5/5/81, A #4 and AV II, 5/4/81, B #1)
Table 4 Enzyme Titration Data
AV I (ul) AV II (Ul) activity (nmole/min)
1() 0.12
5 3.34
10 4.61
15 4.49
25 < ' 3.36
25 () 0.52
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Maximum activity was about 500 nmole/min/ml AV II and the volume
ratio of AV I to AV II (1 to 1) was used to have excess AV I over
AV II.
Procedure:
The reagents were prepared in reaction vials by the following
protocol under anaerobic conditions and placed in water-bath shaker
at 30°C for 6 min.
0.75 mM ATP 1.5 mM ATP
0.5 mM FSBA 0.5 mM FSBA
(unit: ul)
200 mM creatine P 150 150
100 mM Mg acetate 50 50
H 2 145
145
100 mM DTH 200 200
C 2H2 500 500
50 mM ATP 15 30
buffer 300 285
AV I 50 50
DMF or 25 mM FSBA 20 20
Each ATP concentration is comprised of five reaction vials for 5
r
-
FSBA treated and one reaction vial for DMF control. As per time
schedule, 20 ul of creatine kinase solution was added and
immediately after (lOsec), 50 ul AV II was added into the reaction
26
vial which was in water-bath shaker. For the 5'-FSBA treated vials,
after each time interval (1, 2, 3, 4, 5 min after adding AV II),
reaction was stopped by adding 37% HCHO and activity was measured.
For the DMF control vials, reaction was stopped after 5 min of
addition of AV II.
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(6) Initial Fast Inhibition As A Function Of [5'-FSBA] or [ATP]
In experiment (5), 5'-FSBA inhibition was occurring in two
different phases; up to 1 min, the inhibition was occurring very
fast and later it was rather slow. This experiment was designed to
determine the fast inhibition as a function of ATP concentration or
5'-FSBA concentration. The fast inhibition seems to occur
instantaneously, but in this experiment the reaction up to 2 min
was assumed as a reaction containing the initial fast inhibition
for practical reasons.
EXPERIMENT (6)-a. 5'-FSBA inhibition as a function of [ATP]
Reagents:
1. 50 mM ATP and 50 mM Mg acetate solution, pH 7.4.
Since pH could decrease in high [ATP] or [Mg acetate] and
decreased pH could affect the equilibrium of creatine
kinase, mixture of 50 mM ATP and Mg acetate was prepared
adjusting pH to 7.4 by adding 1 M Tris solution.
All the other reagents used were same as experiment 5. The
enzyme solution used was AV I, 5/5/80, A #4 and AV 11,4/16/80.
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Table 5. Enzyme Titration Data
AV I (ul) AV II (ul) activity (nmole/min)
5
10
15
25
25
10 0.1
7.9
14.46
17.48
24.88
0.0
Maximum activity was more that 2,500 nmole/min/ml AV II and the
volume ratio of AVI to AVII (2.5 to 1) was used.
Procedure:
The reagents were prepared by the following protocol under
anaerobic conditions and incubated in water-bath shaker at 30°C for
6 min.
[ATP] (mM) 0.25 1.0 1.5 2.5 5.0 7.5 10.0
(unit: ul)
creatine phosphate 150
H 2 145
100 mM DTH 200 all
C2 H2 gas 500
100 mM Mg acetate 10
AV I 125
50 mM ATP & MgAc 5 20 30 50
buffer 255 240 230 210
DMF or 25 mM FSBA 40 all
same
100 150 200
160 110 60
same
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To get a relative inhibition, each ATP concentration is comprised
of two reaction vials; one for DMF control and the other for 5'-
FSBA treated. 20 ul creatine kinase was added and immediatly after
50 ul AV II was added. After 2 min, reaction was stopped and
activity was measured.
EXPERIMENT (6)-b, Initial fast inhibition as a fuction of [5'-
FSBA]
Reagents:
same as experiment (5), except enzyme solution
Instead of separated components, enzyme mixture containing AVI
and AV II at a ratio of 4 to 1 was used. The enzyme used was
AV I: 5/5/81, A #1 and AV II: 5/4/81, A #1.
Table 6. Enzyme Titration Data
AV I (ul) AV II (Ul) activity (nmole/min)
1() 0.01
5 6.05
10 9.26
15 9.09
25
i
' 12.63
25 () 0.03
Maximum activity was more than 1,300 nmole/min/ml and the volume
ratio of AV I to AV II (4 to 1) was used to have excess AV I over
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AV II.
Procedure:
Five reaction vials for each ATP concentration were
prepared as following protocol anaerobically. As per time schedule,
20 ul creatine kinase solution was added and immediately after
(lOsec) 50 ul enzyme mixture was added into reaction vials which
were being in water-bath shaker. After 2 min of addition of enzyme
solution, reaction was stopped and activity was measured by gas
chromatograph
.
0.25 (0.5 or 1.0 mM) ATP
[5'-FSBA](mM) 0.25
.5 1.0 1.5
(unitrul)
all same
creatine P 150
H 2 180
C2H 2 500
100 mM DTH 200
100 mM Mg acetate 50
50 mM ATP io
buffer 280
DMF 60
25 mM 5'-FSBA °
20 or ' 40 )
( 270 or 250 )
50 40 20
10 20 40 60
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(7) Rate Of Irreversible Inhibition
Experiment (6) showed that 5'-FSBA inhibition on AV II was
ATP concentration dependent; high concentration of ATP prevented
the inhibition by 5'-FSBA. This experiment was designed to get the
rate of irreversible inhibition exploiting above information.
First, AV II was reacted with 5'-FSBA at 0.5 mM of [ATP] and
activity was monitored in every one min up to 5 min. Next, AV II
was reacted with 5'-FSBA at 0.5 mM ATP and in every one minute
instead of terminating reaction, high concentration of ATP stock
solution was added to increase ATP concentration to 2.5 mM and
reaction was terminated after 5 minutes of addition of ATP stock
solution. The difference in activity between theses two reactions
could tell the remaining activity at higher concentration of ATP
and the rate of the remaining activity could tell the rate of
irreversible inhibition that is the inhibition still left at high
concentration of ATP.
Reagents:
same as experiment (6)-a
Also same enzymes were used.
Procedure:
Ten reaction vials containing creatine phosphate (150
ul), H 2 (180 ul), 100 mM DTH (200 ul), C 2 H 2 gas (500 ul), 50 mM
ATP (10 ul), 100 mM Mg acetate (10 ul), buffer (300 ul),
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and 25 mM 5'-FSBA (25 ul) were prepared anaerobically. For five
reaction vials, as per time schedule, 20 ul of creatine kinase was
added and immediately after (lOsec) 50 ul of enzyme was added.
After each time interval (1, 2, 3, 4, 5min after addition of AV
II), the reaction was stopped. For the remaining five reaction
vials, the same procedures were followed except that at each time
interval (1, 2, 3, 4, 5min) instead of terminating the reaction, 40
ul of 50 mM ATP stock solution was added to increase [ATP] to 2.5
mM and reaction was stopped after 5 minutes.
For a DMF control experiment, one reaction vial containing 40
ul of DMF instead of 5'-FSBA at 2.5 mM was prepared. 20 ul
creatine kinase was added and immediately 50 ul enzyme mixture was
added. 5 minutes later reaction was stopped and activity was
measured.
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(8) Fe Determination Of AV II In The Presence Of 5'-FSBA By «*,*-
Dipyridyl
This experiment was designed to determine whether inhibition
by 5'-FSBA on AV II is related with iron sulfur center of Fe
protein; if bound 5'-FSBA reacts with iron-sulfur center and alters
iron-sulfur center reactivity with chelator, &A -dipyridyl, then
different amount of Fe could be detected by o^,oC -dipyridyl in the
presence of 5'-FSBA.
Reagents:
1. 50 mM Tris HC1 buffer, pH 8.0 containing 0.1 M NaCl
2. 20 mM o^rf'- dipyridyl in 50 mM Tris HCl buffer was
prepared anaerobically.
3. 25 mM 5'-FSBA in DMF was prepared anaerobically.
4. N, N - Dimethyl formamide (DMF)
5. 0.1 M Mg acetate solutition in distilled water
6. 50 mM ADP solution in distilled water
7. 100 mM sodium dithionite solution (DTH)
8. AV II
Procedure:
lOOmM 50mM lOOmM .
,
20 mM 25mM
run MgAc ADP buffer DTH AV II <*A -dipyridyl DMF FSBA
(unit: ul)
1 10 10 230 10 500 200 40
2 10 10 230 10 500 200 — 40
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In two cuvettes, the first three constituents in above protocol
were prepared anaerobically, capped tightly using a serum stopper
and evacuated, flushed with Ar gas three times. DTH and enzyme
solution were added using a syringe anaerobically and absorbance at
520 nm was measured for blank. Next, tf,c( -dipyridyl was added and
absorbance was measured for preexisting inactivated AV II. DMF or
5'-FSBA solution was added and aborbance was continuously measured
up to 90 minutes.
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RESULTS
Enzyme Studies
(1) 5'-FSBA Effect On Each Separated Component
Fig (1) and (2) showed that 5'-FSBA had a specific inhibition
effect on AV II but not on AV I. Since Dr. Davis's earlier
observation (unpublished) showed that 5'FSBA inhibition effect was
stronger with MgADP than 5'-FSBA alone, enzyme was reacted with 5'-
FSBA in the presence of MgADP. Almost all of the nitrogenase
activity was inhibited in 2 hours. 5'-FSBA showed an inhibition
effect when a small aliquot of AV II reacted with 5'-FSBA was
diluted into large volume in an assay bottle, indicating that 5'-
FSBA inhibits AV II irreversibly.
N, N - Dimethyl formamide (DMF), the organic solvent used to
dissolve 5'-FSBA showed a litte inhibition effect on nitrogenase
activity, but not any considerable amount. One way to minimize the
DMF effect is to increase 5'-FSBA stock solution concentration in
order to reduce the amount of DMF solution to be used. 25 mM 5'-
FSBA in DMF was likely to be the highest concentration due to
appearance of precipitate in higher concentration. Although I could
increase the 5'-FSBA concentration to 50 mM by dissolving
precipitate in hot water-bath, sometimes 5'-FSBA did not show the
inhibition effect at that concentration, indicating sulfonyl
fluoride group might be hydrolyzed.
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Legend to Figure (l)-a
Figure (l)-a. 5'-FSBA effect on AV I
Figure (l)-a shows 5'-FSBA effect on AV I; 3.4 mM of 5'-FSBA
was reacted with AV I in the presence of 1.0 mM ADP and 2.0 mM
Mg. After indicated reaction time of AV I with 5'-FSBA, a 40
ul aliquot of reaction mixture (containing 9 ul of AV I) was
added to enzyme assay vials (containing 20 ul of AV II) and
assayed for 5 minutes.
O : DMF control
: 5'-FSBA treated
37
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LEGEND to Figure (l)-b
Figure (l)-b. 5'-FSBA effect on AV II
Figure (l)-b shows 5'-FSBA effect on AV II; 3.4 mM of 5'-FSBA
was reacted with AV II in the presence of 1.0 mM ADP and 2.0 mM of
Mg acetate. At the indicated time, a 40 ul aliquot of reaction
mixture containg 9 ul of AVII was added to enzyme assay vials
containing 25 ul of AV I and assayed for 5 minutes.
O : DMF control
: 5'FSBA treated
39
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(2) 5'-FSBA Effect On Mixed Components
5'-FSBA inhibition effect on mixed components was tested for
the purpose of practical use. Figure 2 showed that 5'-FSBA had same
inhibition effect on AV II when AV II was present with AV I in a
mixture. This result allowed me to be able to use the enzyme
solution in a mixture of both components in order to cut off one
adding step, not necessarily reacting AV II with 5'-FSBA and
combining with AV I.
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LEGEND to Figure (2)
Figure (2). 5'-FSBA effect on mixed components
Figure (2) shows 5'-FSBA effect on enzyme mixture; 3.4 mM
5'-FSBA was reacted with 65 ul of enzyme mixture (containing AV I
to AV II at a volume ratio of 2.5 to 1) in the presence of 1.0 mM
ADP and 2.0 mM Mg acetate. After an indicated incubation time, a 40
ul aliquot containing 9 ul enzyme mixture was added to enzyme assay
vials and assayed for 5 minutes at 30°C. Activity was shown as
reduced C2H2 nmole/min/assay.
O : DMF control
: 5'-FSBA treated
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(3) PMSF Effect On AV II
Figure 3 shows the PMSF effect on AV II; although DMF control
was not very constant, the enzyme activity of PMSF treated changed
almost same rate as control, indicating that PMSF did not have any
inhibition effect on AV II.
This result that PMSF which contains same reactive sulfonyl
fluoride group as 5'-FSBA did not inhibit AV II while 5'-FSBA had
an inhibition effect on AV II suggested that 5'-FSBA specifically
inhibited enzyme because not only it had a reactive sulfonyl
fluoride group but also it was a structural analogy to ATP.
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LEGEND to Figure 3
Figure 3. PMSF effect on AV II
Figure 3 shows PMSF effect on AV II; 1 mM of PMSF was reacted
with AV II in the presence of 1.0 mM ATP and 2.0 mM of MgAc. After
indicated reaction time of AV II with PMSF, a 40 ul aliquot of
reaction mixture (containing 10 ul of AV II) was added to enzyme
assay vial (containing 25 ul of AV I) and assayed for 5 minutes.
O ; DMF control
; PMSF treated
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(4) 5'-FSBA Inhibition With MgADP
As shown in Figure (4), 5'-FSBA inhibition with MgADP in the
standard assay medium was much faster than that of experiment 1 or
2; about 90 % of nitrogenase activity was inhibited in 10 minutes
and in 30 minutes almost all of the activity was inhibited
comparing the result of experiment 1 where 20 % activity was
inhibited in 10 minutes and in 2 hours all of the activity was
inhibited. Continuing enzyme turnover in the standard assay medium
might facilitate the 5'-FSBA inhibition effect.
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LEGEND to Figure 4
Figure 4. 5'-FSBA inhibition with MgADP
Figure 4 shows the 5'-FSBA inhibition effect with MgADP in
standard assay medium. 60 ul of AV II was incubated with 1 mM of
5'- FSBA in the presence of 2.5 mM ADP and 5.0 mM MgAc. To measure
inhibition at standatd enzyme assay concentrations, 150 ul of AV I
and the other reagents for assay were added in same vial except
creatine kinase to prevent the conversion of MgADP to MgATP. After
an indicated incubation time with MgADP, enzyme activity was
measured for 5 minutes by adding 20 ul of creatine kinase stock
solution (lOmg/ml).
O : DMF control
: 1 mM 5'-FSBA
48
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(5) Time Course Of 5'-FSBA Inhibition
Figure (5)-a showed the result of time course activity in two
different ATP concentrations (0.75 mM and 1.5 mM) at fixed
concentration of 5'-FSBA, 0.5 mM ; the activity was not increased
proportionally. To determine the inhibition effect directly, the
increment of activity in every one minute was calculated and
plotted as a function of time (shown in figure 5-b). Activity at
minute was derived from the one minute activity with DMF, without
5'-FSBA at each different ATP concentration. Figure (5)-b showed
that 5'-FSBA inhibited the enzyme in two different phases; up to
one minute, inhibition was very fast (half time less than 1 minute)
and later inhibition was occurring rather slowly (half time about 5
to 6 minutes). These two distinct inhibition rates could imply that
the inhibiton might occur in two different ways.
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LEGEND to Figure (5)-a
Figure (5)-a. Time course with 5'-FSBA
Figure (5)-a shows the time course with 5 f -FSBA present at
0.5 mM and two different ATP concentrations of 0.75 mM and 1.5 mM.
In a reaction vial which contains 0.5 mM of 5'-FSBA and reagents
for enzyme assay including 50 ul of AV I, 50 ul of AV II was added
and reacted with 5'-FSBA in two different ATP concentrations. After
every minute interval of addition of AV II, reaction was stopped
and activity was measured.
O :1.5 mM ATP, 0.5 mM5'-FSBA
: 0.75 mM ATP, 0.5 mM 5'-FSBA
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LEGEND to Figure (5)-b
Figure (5)-b. Time course of 5'-FSBA inhibition
Figure (5)-b shows the time course 5'-FSBA inhibition. From
the result of Fig. (5)-a, the increment of activity in every one
minute was calculated and plotted. The activity at minute was
derived from the activity with DMF at different ATP concentration.
O : 1.5 mM ATP, 0.5 mM 5'-FSBA
: 0.75 mM ATP, 0.5 mM 5'-FSBA
53
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(6) Initial Fast Inhibition As A Function Of [ATP] Or [5'-FSBA]
a. Initial inhibition as a function of [ATP]
The results are summarized in table 7. To get a relative
inhibition in different ATP concentrations (0.25, 1.0, 1.5, 2.5,
activity with 5'-FSBA
5.0, 7.5, 10.0 mM), the ratio x 100(%)
activity with DMF control
was calculated and plotted as a function of ATP concentration (see
figure 6-a). 5'-FSBA inhibition was bigger at lower ATP
concentration; at 0.25 mM ATP, about 80% activity was inhibited and
at 1.0 mM ATP, about 55% activity was inhibited. As the
concentration of ATP increased, the inhibition by 5'-FSBA was
decreased; at more than 5 mM of [ATP], 5'-FSBA was likely to have
no inhibition effect. From the result that high concentration of
ATP protects AV II from the inhibition by 5'-FSBA, it is suggested
that 5'-FSBA might compete with ATP in initial reaction. When this
result was plotted in a Dixon plot, 1/v vs [I], it showed that 5'-
FSBA was neither a pure competitive inhibitor nor a pure non-
competitive inhibitor; it showed a competitive inhibititor pattern
between low ATP concentrations (i.e., 1.0 mM and 1.5 mM of ATP) and
it also showed a non-competitive pattern between high ATP
concentrations (i.e., 1.5 mM and 2.5 mM of ATP). 5'-FSBA was likely
to be a mixed inhibitor, reacting with more than one form of the
enzyme.
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Table 7. Initial % Inhibition As A Function Of [ATP]
C: DMFcontrol T:1.0 mM 5'-FSBA T/C xlOO
(nmole/2min) (nmole/2min) (%)
32.35 7.6 23.5
61.30 25.78 42.0
76.05 49.80 65.5
66.60 50.70 76.1
58.90 66.60 113.0
63.80 51.10 80.0
49.8 44.1 88.0
[ATP] (mM)
0. 25
1 .0
1.,5
2 .5
5.,0
7 .5
10.,0
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b. Initial Inhibition As A Function Of [5'-FSBA]
The results are shown in Dixon plots, l/v vs [I] at two
different fixed ATP concentrations; figure 6-b shows a plot of 0.25
mM and 0.5 mM ATP concentration and figure 6-c shows a plot of 0.5
mM and 1.0 mM of ATP concentration. Although the same enzyme was
used for these two set of experiments, the experiments were not
performed in same day. Since enzyme loses its activity during the
process of repeated freezing and thawing, the results of two
experiments could not compared in a same scale. Both figure 6-b and
6-c show a competitive inhibitor pattern and Ki, the binding
constant ot 5'-FSBA on AV II was graphically obtained which was
approximately 0.5 mM. This Ki value is almost the same as the
reported Km value of MgATP to Fe protein which is 0.5 mM (1),
indicating that 5'-FSBA competes with MgATP having a similar
affinity at low ATP concentrations.
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LEGEND to Figure 6-a
Figure 6-a. Initial % inhibition as a function of ATP
Figure 6-a shows the initial % inhibition as a function of
[ATP]. At several different ATP concentrations (0.25, l.o, 1.5,
2.5, 5.0, 7.5, 10.0) with fixed 5'-FSBA concentration of 1.0 mM or
with DMF, 50 ul of AV II was added and 2 minutes after reaction was
stopped. % inhibition was calculated as follows and plotted as a
fuction of [ATP].
T (activity with 5'-FSBA)
x 100, at each ATP concentration
C (activity with DMF)
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LEGEND to Figure (6)-b
Figure 6-b. Dixon plot of initial inhibition (I)
Figure 6-b shows the Dixon plot at two different fixed
concentrations of ATP, 0.25 and 0.5 mM. In reaction vials of
several different 5'-FSBA concentrations, 50 ul enzyme mixture was
added and activity was measured after 2 minutes. The Ki value was
obtained graphically, approximately 0.5 mM.
0.25 mM ATP
—O —
0.5 mM ATP — A —
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LEGEND to Figure (6)-c
Figure 6-c. Dixon plot of initial inhibition (II)
Figure 6-c shows the Dixon plot of two different fixed ATP
concentrations, 0.5 and 1.0 mM. The Ki value was obtained,
approximately 0.5 mM.
0.5 mM ATP A
1.0 mM ATP D
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(7) Rate Of Irreversible Inhibition
The results are summarized in Table 8. The remaining
activity after increasing of [ATP] was calculated per unit reaction
time and this data was plotted as a function of time. time
activity was the DMF control activity for 1 minute at 2.5 mM ATP
concentration. Figure 7 shows the rate of irreversible inhibition;
half time was about 7-8 minutes. This irreversible inhibition was
relatively slow compared to the initial fast inhibition whose half
time was less than 1 minute (figure 5-b). This difference could
suggest that initial fast inhibition might occur in a different
way, i.e., reversible inhibition competing with ATP. This
irreversible inhibition rate was comparable to the rate of initial
inhibition with MgADP alone whose half time was about 7 minutes
(figure 4).
These overall data suggest that 5'-FSBA inhibition on Fe
protein of Azotobacter vinelandii was occurring in two different
steps; fast reversible inhibition competing with ATP followed by
relatively slow irreversible inhibition on AV II.
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Table 8. Determination Of Rate Of Irreversible Inhibition
products formed productsformed with net
with 0.5 mM ATP 0.5 mM + 2.5 mM ATP activity in
time (nmole) (nmole) second stage
(nmole/min)
1 min 6.4 77.6 77.6-6.4/5 = 14.24
2 min 11.75 61.6 61.6-11.75/5 = 9.97
3 min 14.5 68.3 68.3-14.5/5 = 10.76
4 min 18.6 61.65 61.65-18.6/5 = 8.61
"5 min 19.5 60.77 60.77-19.5/5 = 8.25
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LEGEND to figure (7)
Figure 7. Rate of irreversible inhibition
Fig. 7 shows the rate of irreversible inhibition on AV II by
1.0 mM of 5'-FSBA (see text for detail).
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(8) Fe detection of AV II in the presence of 5'-FSBA by o(,fc -
dipyridyl
The results are shown at figure 8 and summarized in table
9. The absorbance at (a) was measured for blank and increased
absorbanse by adding <L,<k -dipyridy at (b) was due to the released
Fe from preexisting denatured protein. The measured absorbance by
adding DMF or 5'-FSBA was regared as min absorbance. The result
showed that in 10 minutes after adding 5'-FSBA, a large absorbance
change occurred (0.426 - 0.372 = 0.054); this absorbance change was
approximately equal to 0.0064 mM of Fe since molar absorptivity of
the colored product is 8,400. While, DMF control did not release
Fe in 10 minutes, as expected (30). Since the protein used showed
the activity of 1,000 nmole/min/ml and specific activity of
component II is to be 2,000 nmole/min/mg, about 0.5 mg/ml of
protein was active in the enzyme used; this is approximately 0.008
mM (molecular weight of component II is 60,000). Therefore the
absorbance change in 10 minutes was caused by about 0.8 Fe released
(0.0064 mmole Fe/0.008 mmole protein = 0.8 Fe/protein).
After 30 minutes, DMF control released Fe almost same rate
as 5'-FSBA treated. Since reduced AV II with MgADP is not supposed
to release Fe (30), this result is not expected. Absolute
absorbance change of 5'-FSBA treated could not be calculated as
released Fe since control was not constant after 30 minutes.
Probably uncontrolled temperature could be one reason to increase
the absorbance of control; the use of spectrophotometer for a long
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time could heat the detector and increase the baseline of
absorbance. Subtracting the increased absorbance of control from
that of 5'-FSBA treated, 5'-FSBA caused no further of Fe released
after 10 min. This result showed that 5'-FSBA might affect the
comformation around the iron sulfur center and expose the iron
sulfur center to chelator in the beginning of its reaction.
Table 9. Fe Detection Of AV II With 5'-FSBA
Absorbance at 520 nm
Time C (DMF control) T (5'-FSBA treated)
a. MgADP, buffer, 0.201 0.276
AV II, DTH added
0.360
0.372
0.426
0.436
0.444
0.454
0.480
0.502
This result shows that chelation by UM -dipyridyl could provide
the way to determine whether 5'-FSBA inhibition was caused by the
change of iron sulfur center activity or not. But to get a more
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b. g(.4 -di pyr'idyl added 0.330
c. DMF or 5'-FSBA added 0.348
(0 min)
d. 5 min 0.348
e. 10 min 0.350
f. 20 min 0.354
g. 30 min 0.358
h. 60 min 0.382
i. 90 min 0.408
reliable data, this experiment should be done more carefully,
considering the followings.
a) Temperature should be controlled at 25°C constantly.
b) Purification of enzyme may be helpful to get an accurate
measurement.
c) It would be necessary to confirm that the measured
absorbance reflected the total Fe released for precise
quantitative interpretation of data.
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LEGEND to Figure 8
Figure 8. Fe chelation by c<,<* -dipyridyl
Figure 8 shows the absorbance at 520 nm with reduced AV II,
and oLA -dipyridyl in pH 8.0, 50 mM Tris.HCl buffer containing 0.1 M
Nacl in two different conditions; with 5'-FSBA or DMF.
— : reduced AV II + MgADP + DMF
: reduced AV II + MgADP + 5'-FSBA
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CONCLUSION
The Iron protein of Azotobacter vinelandii nitrogenase was
studied using an ATP analog, 5'-Fluorosulfonyl benzoyl adenosine
(5'-FSBA). 5'-FSBA inhibited the Fe protein but not the MoFe
protein. Since 5'-FSBA contains electrophi 1 ic sulfonyl fluoride
group, the specificity of 5'-FSBA inhibition on AV II was tested;
phenyl methane sulfonyl fluoride (PMSF) which contains the same
sulfonyl fluoride group does not inhibit the AV II, indicating that
5'-FSBA has a specific inhibition effect on AV II due to its
structural analogy to ATP.
Dr Davis's earlier observation that 5'-FSBA inhibition was
stronger in the presence of MgADP than 5'-FSBA alone was consistent
with my following result. At high ATP concentration, 5'-FSBA did
not inhibit the enzyme. However, when the reaction continues for a
longer time, creatine phosphate is running out and the equilibrium
of ATP regenerating reaction is no longer overwhelmingly in the
favor of ATP production, resulting the increase of the
concentration of MgADP. When the MgADP concentration is increased
for a longer reaction time, 5'-FSBA begins to inhibit the AV II
(data are not shown).
5'-FSBA inhibition on Fe protein was occurring in two
different steps. It could be treated as instantaneous reversible
inhibition competing with ATP followed by relatively slow (half
time about 7 minutes) irreversible inhibition on AV II. The
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result of Dixon plot showed that 5'-FSBA is a mixed inhibitor
reacting with more than one form of enzyme. Ki value was obtained
form the Dixon plot between low ATP concentrations. The Ki obtained
was approximately the same as the reported Km of AV II for MgATP
indicating that 5'-FSBA competes with MgATP having a similar
affinity.
Irreversible inhibition on AV II by 5'-FSBA could occur in
several possible ways; modification of active amino acid residue or
comformational change of iron sulfur center could be one of them.
,/
The latter possibility was tested using the Fe chelator, c* ; *-
dipyridyl. 5'-FSBA caused about one mole of Fe release out of four
per protein molecule in 10 minutes, whereas DMF control did not
release Fe, indicating 5'-FSBA inhibition may relate to the
changing activity of iron sulfur center. However the rate of Fe
release was not constant; very quick Fe release in 10 minutes
(about 0.8 mole of Fe per mole or protein), slow Fe release in 30
minutes (0.2 mole Fe release between 10 minutes and 30 minutes),
and no net Fe release after 30 minutes. Therefore more thorough
experiment should be performed to conclude the relationship between
the irreversible inhibition and the change of iron sulfur center
activity and a more precise quantitative interpretation should be
supported.
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The Iron protein of Azotobacter vinelandii nitrogenase was
studied by an ATP analog, 5'-Fluorosulfonyl benzoyl adenosine (5'-
FSBA). 5'-FSBA was a specific inhibitor to the Fe protein but not
to theMoFe protein. The inhibition by 5'-FSBA was occurring in two
different ways; instantaneous reversible inhibition competing with
ATP followed by irreversible inhibition. 5'-FSBA was likely to be a
mixed inhibitor, reacting more than one form of the enzyme. The Ki
value was obtained between low ATP concentrations; it showed that
5'-FSBA competes with MgATP having a similar affinity.
The relationship between irreversible inhibition and the
change of iron sulfur center activity was examined using an iron-
chelating agent, d,<*> -dipyridyl.
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